日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Use of artificial intelligence to draft a mini-HTA report on a new medical device belonging to class IIb-III

利用人工智能技术撰写一份关于属于IIb-III类医疗器械的小型卫生技术评估报告

Messori, Andrea; Beltramini, Sabrina; Crosasso, Paola; Fruttero, Claudia; Rivano, Melania; Chiumente, Marco; Silvani, Maria C

Evolving bioanalytical strategies in the wake of pioneering biotherapeutics

随着开创性生物疗法的出现,生物分析策略也在不断发展。

Riccardi Sirtori, Federico; Di Ianni, Andrea; Crosasso, Claudio; Bertotti, Elisa; Molinaro, Francesco; De Salve, Ilse; Barbero, Luca; Cowan, Kyra J

Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab

在接受利妥昔单抗治疗的肾小球疾病患者中,使用替沙维单抗/西加维单抗(Evusheld)进行暴露前预防的安全性和有效性

Sciascia, Savino; Rilat, Maria Letizia Antonietta; Fenoglio, Roberta; Foddai, Silvia Grazietta; Radin, Massimo; Cecchi, Irene; Cinnirella, Giacoma; Crosasso, Paola; Guidetti, Maria Gabriella; Barinotti, Alice; Baldovino, Simone; Menegatti, Elisa; Roccatello, Dario

Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTORApp-A Usability Study

针对类风湿性关节炎患者,量身定制托法替尼口服治疗方案:TuTORApp——一项可用性研究

Sciascia, Savino; Radin, Massimo; Cecchi, Irene; Di Nunzio, Pierluigi; Buccarano, Nicola; Di Gregorio, Federico; Valeria, Milone; Osella, Sara; Crosasso, Paola; Favuzzi, Marika Denise; Rubini, Elena; Foddai, Silvia Grazietta; Baldovino, Simone; Roccatello, Dario; Rossi, Daniela